Real-time Tumor Visualization
Total Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
618
NCT02973672
Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2016
Completion: May 31, 2019
NCT03659448
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Phase: Phase 3
Start: Jun 17, 2019
Completion: Dec 31, 2024
NCT04642924
SGM-101 in Locally Advanced and Recurrent Rectal Cancer
Phase: Phase 2/3
Role: Collaborator
Start: Oct 22, 2019
Completion: Oct 31, 2023
NCT04737213
SGM-101 in Colorectal Lung Metastases
Phase: Phase 2
Start: Nov 1, 2020
Completion: Dec 1, 2021
NCT04755920
SGM-101 in Colorectal Brain Metastases.
Start: Jan 1, 2024
Completion: Feb 28, 2026
NCT05984810
NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101
Start: Mar 18, 2024
Completion: Dec 31, 2026
Loading map...